C. Kreft-Jaïs - Concepedia

Author

C. Kreft-Jaïs

Also Known As

C Kreft-Jais, C. Kreft-Jais, C. Kreft-Jaïs, C. Kreft‐Jais, CARMEN KREFT-JAIS, Carmen Kreft-Jais, Carmen Kreft-Jaïs, Carmen Kreft‐Jais, Françoise Haramburu, O. Clement

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Hôpital Broussais Inserm Bordeaux Population Health Agence Nationale de Sécurité du Médicament et des Produits de Santé Institut National de Prévention et d’Education pour la Santé

About

C. Kreft-Jaïs is an author at Hôpital Broussais specializing in medicine, pharmacology, and pharmacovigilance.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	460
2	Public Health	4	4	80
3	Health Sciences	1	1	13
4	Biostatistics	1	1	11
5	Endocrinology	1	1	32

C. Kreft-Jaïs

Publications

872

Citations

H-Index

Page 1

	Year	Citations
Efficacy and tolerance of spironolactone in essential hypertension Xavier Jeunemaı̂tre, Gilles Châtellier, C. Kreft-Jaïs, The American Journal of Cardiology HypertensionCardiovascular DiseaseMedicineAntihypertensive TherapyCardiovascular Pharmacology	1987	270
Reports of hypoglycaemia associated with the use of ACE inhibitors and other drugs: a case/non‐case study in the French pharmacovigilance system database Nicholas M. Moore, C. Kreft-Jaïs, Françoise Haramburu, British Journal of Clinical Pharmacology	1997	137
Bayesian pharmacovigilance signal detection methods revisited in a multiple comparison setting Ismaïl Ahmed, Françoise Haramburu, Annie Fourrier‐Réglat, Statistics in Medicine	2009	70
[French pharmacovigilance database system: examples of utilisation]. Nicholas Moore, C. Noblet, C. Kreft-Jaïs, PubMed	1996	57
CYCLOSPORINE-INDUCED STIMULATION OF THE RENIN-ANGIOTENSIN SYSTEM AFTER LIVER AND HEART TRANSPLANTATION J Julien, Dominique Farge, C. Kreft-Jaïs, Transplantation	1993	46
Adverse drug reactions in patients with Alzheimer's disease and related dementia in France: a national multicentre cross‐sectional study Marie‐Laure Laroche, Marie‐Christine Pérault‐Pochat, Isabelle Ingrand, Pharmacoepidemiology and Drug Safety	2013	45
Isotretinoin Exposure during Pregnancy E. Autret‐Leca, C. Kreft-Jaïs, Élisabeth Éléfant, Drug Safety MedicineDevelopmental ToxicologyGynecologyMaternal HealthPregnancy	2010	32
First French Experience of ADR Reporting by Patients After a Mass Immunization Campaign with Influenza A (H1N1) Pandemic Vaccines Geneviève Durrieu, Aurore Palmaro, Laure Pourcel, Drug Safety VaccinationVaccine SafetyFirst French ExperienceVaccine EfficacyAdr Reporting	2012	30
Early Detection of Pharmacovigilance Signals with Automated Methods Based on False Discovery Rates Ismaïl Ahmed, Frantz Thiessard, Ghada Miremont‐Salamé, Drug Safety Drug SafetyTherapeutic Drug MonitoringHit IdentificationPharmacovigilance SignalsMedicine	2012	29
Association between concomitant use of several systemic NSAIDs and an excess risk of adverse drug reaction. A case/non-case study from the French Pharmacovigilance system database François Clinard, Catherine Sgro, Marc Bardou, European Journal of Clinical Pharmacology Drug SafetyDrug InteractionsSubstance AbuseMedicinePatient Safety	2004	27

Page 1